acetaminophen 325 MG / phenyltoloxamine citrate 30 MG Oral Tablet [Contragesic]
RxNorm concept 2391610, branded drug (sbd). Prescribable name: Contragesic 325 MG / 30 MG Oral Tablet.
- RxCUI
- 2391610
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2391610 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
APAP 325 MG / phenyltoloxamine citrate 30 MG Oral Tablet [Contragesic]; Contragesic (acetaminophen 325 MG / phenyltoloxamine citrate 30 MG) Oral Tablet
Related concepts
- acetaminophen 325 MG (SCDC, consists of)
- phenyltoloxamine citrate 30 MG (SCDC, consists of)
- acetaminophen 325 MG / phenyltoloxamine citrate 30 MG [Contragesic] (SBDC, consists of)
- Oral Tablet (DF, has dose form)
- Contragesic (BN, has ingredient)
- acetaminophen 325 MG / phenyltoloxamine citrate 30 MG Oral Tablet (SCD, tradename of)
Linked data
NDCs
- 10267100001
- 10267100009
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2391610 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2391610 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2391610. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.